Suchergebnisse - "Pizzuti, Laura"

PubPharm (193)

1

DARPP-32 and t-DARPP in the development of resistance to anti-HER2 agents. Pre-clinical evidence from the STEP study

enthalten in: Neoplasia (New York, N.Y.) | 2023

von Bon, G. | Krasniqi, E. | Porru, M. | +17

2

Sexual dysfunctions in breast cancer patients : evidence in context

enthalten in: Sexual medicine reviews | 2023

von Vizza, R. | Capomolla, E. | Tosetto, L. | +19

3

Pathologic response and survival after neoadjuvant chemotherapy with or without pertuzumab in patients with HER2-positive breast cancer : the Neopearl nationwide collaborative study

enthalten in: Frontiers in oncology | 2023

von Fabbri, A. | Nelli, F. | Botticelli, A. | +23

4

Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment : real-world evidence from CaRe, a multicentric, observational study

enthalten in: Frontiers in oncology | 2023

von Di Lisa, F. | Krasniqi, E. | Pizzuti, L. | +81

5

Role of advanced imaging techniques in the evaluation of oncological therapies in patients with colorectal liver metastases

enthalten in: World journal of gastroenterology | 2023

von Caruso, M. | Stanzione, A. | Prinster, A. | +4

6

Prognostic value of [18F]-FDG PET/CT in patients with meta-static breast cancer treated with cyclin-dependent inhibitors

enthalten in: Frontiers in oncology | 2023

von Annovazzi, A. | Rea, S. | Maccora, D. | +5

7

Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer : Hints from Liquid Biopsy and microRNA Exploration

enthalten in: International journal of molecular sciences | 2022

von Krasniqi, E. | Goeman, F. | Pulito, C. | +13

8

Rising incidence of late stage breast cancer after COVID-19 outbreak. Real-world data from the Italian COVID-DELAY study

enthalten in: Breast (Edinburgh, Scotland) | 2022

von Mentrasti, G. | Cantini, L. | Vici, P. | +17

9

The Impact of the Hippo Pathway and Cell Metabolism on Pathological Complete Response in Locally Advanced Her2+ Breast Cancer : The TRISKELE Multicenter Prospective Study

enthalten in: Cancers | 2022

von Krasniqi, E. | Di Lisa, F. | Di Benedetto, A. | +27

10

Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B

enthalten in: Nature immunology | 2022

von Musella, M. | Guarracino, A. | Manduca, N. | +40

CommentIn: Nat Immunol. 2022 Sep;23(9):1300-1302. - PMID 36002649

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]